财信证券晨会纪要-20250820

Market Strategy - The market experienced a pullback after a rise, with the liquor sector rebounding [7] - The overall A-share market saw a slight decline, with the Shanghai Composite Index down 0.02% and the ChiNext Index down 0.17% [7][8] - Small and micro-cap stocks outperformed larger stocks, with the North Star 50 Index increasing by 1.27% [7] Economic Insights - From January to July, the national general public budget revenue grew by 0.1% year-on-year, with tax revenue declining by 0.3% [14][15] - The People's Bank of China conducted a 7-day reverse repurchase operation of 580.3 billion yuan, indicating a net injection of 465.7 billion yuan into the market [18][19] Industry Dynamics - The National Radio and Television Administration encourages the broadcasting of micro-short dramas and the introduction of excellent foreign programs [25] - In July 2025, China's gaming market revenue grew by 4.62% year-on-year, with self-developed games' overseas revenue increasing by 6.76% [27][28] Company Tracking - For Hebang Bio (603077.SH), the methionine business saw explosive growth, with the company achieving a revenue of 3.921 billion yuan in the first half of 2025 [29][30] - Xinda Co., Ltd. (603086.SH) reported a revenue of 1.423 billion yuan, a year-on-year increase of 11.82%, driven by a recovery in the pesticide market [32][33]